{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:10:55Z","timestamp":1793326255204,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.heliyon.2024.e26701","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T02:52:22Z","timestamp":1708397542000},"page":"e26701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Revisiting luteolin: An updated review on its anticancer potential"],"prefix":"10.1016","volume":"10","author":[{"given":"Abdur","family":"Rauf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polrat","family":"Wilairatana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal B.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubair","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Olatunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabia","family":"Hafeez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan A.","family":"Hemeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9782-0835","authenticated-orcid":false,"given":"Mohammad S.","family":"Mubarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e26701_bib1","author":"WHO","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.heliyon.2024.e26701_bib2","series-title":"Anticancer Drug Resistance: an Update and Perspective","author":"Nussinov","year":"2021"},{"key":"10.1016\/j.heliyon.2024.e26701_bib3","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3390\/antiox10091455","article-title":"Role of phytochemicals in cancer chemoprevention: insights","volume":"10","author":"George","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.heliyon.2024.e26701_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01634-9","article-title":"Autophagy regulation using luteolin: new insight into its anti-tumor activity","volume":"20","author":"Ashrafizadeh","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.heliyon.2024.e26701_bib5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/156800908786241050","article-title":"Luteolin, a flavonoid with potential for cancer prevention and therapy","volume":"8","author":"Lin","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.heliyon.2024.e26701_bib6","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.numecd.2020.02.014","article-title":"Protective effects of luteolin against oxidative stress and mitochondrial dysfunction in endothelial cells, Nutrition","volume":"30","author":"Chen","year":"2020","journal-title":"Metabolism and Cardiovascular Diseases"},{"key":"10.1016\/j.heliyon.2024.e26701_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108612","article-title":"Luteolin, a flavonoid, as an anticancer agent: a review","volume":"112","author":"Imran","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e26701_bib8","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3389\/fphar.2019.01551","article-title":"Luteolin exerts neuroprotection via modulation of the p62\/Keap1\/Nrf2 pathway in intracerebral hemorrhage","volume":"10","author":"Tan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e26701_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fpain.2023.1114428","article-title":"Luteolin: a promising natural agent in management of pain in chronic conditions","volume":"4","author":"Ntalouka","year":"2023","journal-title":"Frontiers in Pain Research"},{"key":"10.1016\/j.heliyon.2024.e26701_bib10","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3390\/nu14061155","article-title":"Anti-inflammatory and active biological properties of the plant-derived bioactive compounds luteolin and luteolin 7-glucoside","volume":"14","author":"Caporali","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2024.e26701_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12032-021-01508-8","article-title":"Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition","volume":"38","author":"Hussain","year":"2021","journal-title":"Med. Oncol."},{"key":"10.1016\/j.heliyon.2024.e26701_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.21614\/chirurgia.116.2.170","article-title":"Breast cancer apoptosis and the therapeutic role of luteolin","volume":"116","author":"Fasoulakis","year":"2021","journal-title":"Chirurgia"},{"key":"10.1016\/j.heliyon.2024.e26701_bib13","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.7314\/APJCP.2014.15.14.5501","article-title":"Luteolin, a bioflavonoid inhibits colorectal cancer through modulation of multiple signaling pathways: a review","volume":"15","author":"Pandurangan","year":"2014","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.heliyon.2024.e26701_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2022.101740","article-title":"Luteolin inhibits viability, migration, angiogenesis and invasion of non-small cell lung cancer vascular endothelial cells via miR-133a-3p\/purine rich element binding protein B-mediated MAPK and PI3K\/Akt signaling pathways","volume":"75","author":"Pan","year":"2022","journal-title":"Tissue Cell"},{"key":"10.1016\/j.heliyon.2024.e26701_bib15","first-page":"1699","article-title":"Luteolin potentially treating prostate cancer and COVID-19 analyzed by the bioinformatics approach: clinical findings and drug targets","author":"Ye","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e26701_bib16","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.3390\/molecules13102628","article-title":"Anti-carcinogenic effects of the flavonoid luteolin","volume":"13","author":"Seelinger","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e26701_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92135-w","article-title":"Syntheses of mono-acylated luteolin derivatives, evaluation of their antiproliferative and radical scavenging activities and implications on their oral bioavailability","volume":"11","author":"Lo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e26701_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmech.2015.04.056","article-title":"Exploring quercetin and luteolin derivatives as antiangiogenic agents","volume":"97","author":"Ravishankar","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26701_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/mp\/ssp106","article-title":"Phenylpropanoid biosynthesis","volume":"3","author":"Vogt","year":"2010","journal-title":"Mol. Plant"},{"key":"10.1016\/j.heliyon.2024.e26701_bib20","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/79025","article-title":"Structure and mechanism of the evolutionarily unique plant enzyme chalcone isomerase","volume":"7","author":"Jez","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.heliyon.2024.e26701_bib21","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3390\/metabo12111145","article-title":"Recent updates on source, biosynthesis, and therapeutic potential of natural flavonoid luteolin: a review","volume":"12","author":"Muruganathan","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.heliyon.2024.e26701_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-022-02808-3","article-title":"Luteolin: a flavonoid with a multifaceted anticancer potential","volume":"22","author":"Prasher","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.heliyon.2024.e26701_bib23","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/vaccines11030554","article-title":"Therapeutic potential of luteolin on cancer","volume":"11","author":"\u00c7etinkaya","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.heliyon.2024.e26701_bib24","first-page":"3842","article-title":"Luteolin inhibits cell cycle progression and induces apoptosis of breast cancer cells through downregulation of human telomerase reverse transcriptase","volume":"17","author":"Huang","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.heliyon.2024.e26701_bib25","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s12272-001-2107-0","article-title":"Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells","volume":"31","author":"Choi","year":"2008","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.heliyon.2024.e26701_bib26","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3390\/ijms24032136","article-title":"Immunopharmacological activities of luteolin in chronic diseases","volume":"24","author":"Huang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e26701_bib27","first-page":"1559","article-title":"Modulation of G2\/M cell cycle arrest and apoptosis by luteolin in human colon cancer cells and xenografts","volume":"15","author":"Chen","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.heliyon.2024.e26701_bib28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/01635581.2021.1903947","article-title":"Luteolin induces apoptosis and autophagy in HCT116 colon cancer cells via p53-dependent pathway","volume":"74","author":"Yoo","year":"2022","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.heliyon.2024.e26701_bib29","first-page":"1","article-title":"Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells","volume":"51","author":"Kang","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e26701_bib30","first-page":"2231","article-title":"Luteolin, an aryl hydrocarbon receptor ligand, suppresses tumor metastasis in vitro and in vivo","volume":"44","author":"Feng","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.heliyon.2024.e26701_bib31","doi-asserted-by":"crossref","first-page":"10998","DOI":"10.1080\/21655979.2022.2066926","article-title":"Luteolin impacts deoxyribonucleic acid repair by modulating the mitogen-activated protein kinase pathway in colorectal cancer","volume":"13","author":"Song","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.heliyon.2024.e26701_bib32","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.7150\/jca.27183","article-title":"Luteolin exerts an anticancer effect on gastric cancer cells through multiple signaling pathways and regulating miRNAs","volume":"9","author":"Pu","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e26701_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-015-0398-z","article-title":"Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer","volume":"13","author":"Lu","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e26701_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-017-1151-6","article-title":"Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway","volume":"15","author":"Zang","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e26701_bib35","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bbrc.2017.06.140","article-title":"Luteolin suppresses angiogenesis and vasculogenic mimicry formation through inhibiting Notch1-VEGF signaling in gastric cancer","volume":"490","author":"Zang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e26701_bib36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2147\/CMAR.S149619","article-title":"Gastric cancer: epidemiology, prevention, classification, and treatment","volume":"10","author":"Sitarz","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.heliyon.2024.e26701_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1055\/s-0034-1391284","article-title":"Long-term survival after endoscopic resection versus surgery in early gastric cancers","volume":"47","author":"Kim","year":"2015","journal-title":"Endoscopy"},{"key":"10.1016\/j.heliyon.2024.e26701_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.38","article-title":"Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1","volume":"8","author":"Song","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e26701_bib39","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.tiv.2011.05.009","article-title":"Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells","volume":"25","author":"Cai","year":"2011","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.heliyon.2024.e26701_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cbi.2016.07.028","article-title":"Luteolin exerts pro-apoptotic effect and anti-migration effects on A549 lung adenocarcinoma cells through the activation of MEK\/ERK signaling pathway","volume":"257","author":"Meng","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.heliyon.2024.e26701_bib41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.fct.2013.02.022","article-title":"Induction of endoplasmic reticulum stress-mediated apoptosis and non-canonical autophagy by luteolin in NCI-H460 lung carcinoma cells","volume":"56","author":"Park","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e26701_bib42","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.3892\/mmr.2015.3956","article-title":"Luteolin exerts an anticancer effect on NCI-H460 human non-small cell lung cancer cells through the induction of Sirt1-mediated apoptosis","volume":"12","author":"Ma","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.heliyon.2024.e26701_bib43","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1111\/jcmm.16568","article-title":"Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo","volume":"25","author":"Zhang","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e26701_bib44","doi-asserted-by":"crossref","first-page":"8203","DOI":"10.2174\/0929867328666210720143721","article-title":"The role of tumor associated macrophages (TAMs) in cancer progression, chemoresistance, angiogenesis and metastasis-current status","volume":"28","author":"Dallavalasa","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26701_bib45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbrc.2016.01.002","article-title":"Luteolin inhibits recruitment of monocytes and migration of Lewis lung carcinoma cells by suppressing chemokine (C\u2013C motif) ligand 2 expression in tumor-associated macrophage","volume":"470","author":"Choi","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e26701_bib46","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.heliyon.2024.e26701_bib47","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.canlet.2021.05.019","article-title":"Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer","volume":"515","author":"Jiang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.heliyon.2024.e26701_bib48","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3892\/ijo.2015.2831","article-title":"Luteolin acts as a radiosensitizer in non-small cell lung cancer cells by enhancing apoptotic cell death through activation of a p38\/ROS\/caspase cascade","volume":"46","author":"Cho","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.heliyon.2024.e26701_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107914","article-title":"Luteolin activates Tregs to promote IL-10 expression and alleviating caspase-11-dependent pyroptosis in sepsis-induced lung injury","volume":"99","author":"Zhang","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.heliyon.2024.e26701_bib50","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cyto.2018.03.042","article-title":"Luteolin attenuates acute lung injury in experimental mouse model of sepsis","volume":"110","author":"Rungsung","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.heliyon.2024.e26701_bib51","first-page":"2021","article-title":"Luteolin regulates the differentiation of regulatory T cells and activates IL-10-dependent macrophage polarization against acute lung injury","author":"Xie","year":"2021","journal-title":"Journal of Immunology Research"},{"key":"10.1016\/j.heliyon.2024.e26701_bib52","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jfma.2016.08.009","article-title":"Chemotherapeutic effects of luteolin on radio-sensitivity enhancement and interleukin-6\/signal transducer and activator of transcription 3 signaling repression of oral cancer stem cells","volume":"115","author":"Tu","year":"2016","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.heliyon.2024.e26701_bib53","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7314\/APJCP.2013.14.2.631","article-title":"Comparative studies to evaluate relative in vitro potency of luteolin in inducing cell cycle arrest and apoptosis in HaCaT and A375 cells","volume":"14","author":"George","year":"2013","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.heliyon.2024.e26701_bib54","doi-asserted-by":"crossref","first-page":"723","DOI":"10.21873\/anticanres.14003","article-title":"Luteolin-regulated MicroRNA-301-3p targets caspase-8 and modulates TRAIL sensitivity in PANC-1 cells","volume":"40","author":"Moeng","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.heliyon.2024.e26701_bib55","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/carcin\/bgab017","article-title":"DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer","volume":"42","author":"Kato","year":"2021","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.heliyon.2024.e26701_bib56","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1039\/C8FO00033F","article-title":"The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2","volume":"9","author":"Li","year":"2018","journal-title":"Food Funct."},{"key":"10.1016\/j.heliyon.2024.e26701_bib57","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1158\/1535-7163.MCT-09-0191","article-title":"Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin","volume":"8","author":"Zhou","year":"2009","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.heliyon.2024.e26701_bib58","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.21873\/anticanres.11234","article-title":"Dietary flavonoids luteolin and quercetin suppressed cancer stem cell properties and metastatic potential of isolated prostate cancer cells","volume":"36","author":"Tsai","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.heliyon.2024.e26701_bib59","article-title":"Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis","volume":"7","author":"Pratheeshkumar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e26701_bib60","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1002\/ijc.26284","article-title":"Upregulation of prostate\u2010derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells","volume":"130","author":"Tsui","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e26701_bib61","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/carcin\/bgz193","article-title":"Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer","volume":"41","author":"Naiki-Ito","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.heliyon.2024.e26701_bib62","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/cells9020460","article-title":"Natural compounds in prostate cancer prevention and treatment: mechanisms of action and molecular targets","volume":"9","author":"Fontana","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.heliyon.2024.e26701_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.59566\/IJBS.2012.8219","article-title":"Multiple sites of type II site ligand (luteolin and BMHPC) regulation of gene expression in PC-3 cells","volume":"8","author":"Markaverich","year":"2012","journal-title":"Int. J. Biomed. Sci.: IJBS"},{"key":"10.1016\/j.heliyon.2024.e26701_bib64","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1038\/s41598-018-26761-2","article-title":"Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics","volume":"8","author":"Han","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e26701_bib65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA","volume":"71","author":"Sung","year":"2021","journal-title":"A Cancer Journal for Clinicians"},{"key":"10.1016\/j.heliyon.2024.e26701_bib66","article-title":"Luteolin enhances the antitumor efficacy of oncolytic vaccinia virus that harbors IL\u201024 gene in liver cancer cells","volume":"35","author":"Wang","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.heliyon.2024.e26701_bib67","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1159\/000484066","article-title":"Luteolin promotes cell apoptosis by inducing autophagy in hepatocellular carcinoma","volume":"43","author":"Cao","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.heliyon.2024.e26701_bib68","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1159\/000484066","article-title":"Luteolin promotes cell apoptosis by inducing autophagy in hepatocellular carcinoma","volume":"43","author":"Cao","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.heliyon.2024.e26701_bib69","first-page":"665","article-title":"Luteolin sensitizes human liver cancer cells to TRAIL-induced apoptosis via autophagy and JNK-mediated death receptor 5 upregulation","volume":"54","author":"Nazim","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.heliyon.2024.e26701_bib70","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/ndt\/gfq528","article-title":"Luteolin ameliorates cisplatin-induced acute kidney injury in mice by regulation of p53-dependent renal tubular apoptosis","volume":"26","author":"Kang","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.heliyon.2024.e26701_bib71","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jnutbio.2009.04.004","article-title":"Soy isoflavones and virus infections","volume":"20","author":"Andres","year":"2009","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.heliyon.2024.e26701_bib72","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1142\/S0192415X20500603","article-title":"MLL3 induced by luteolin causes apoptosis in tamoxifen-resistant breast cancer cells through H3K4 monomethylation and suppression of the PI3K\/AKT\/mTOR pathway","volume":"48","author":"Wu","year":"2020","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.heliyon.2024.e26701_bib73","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.2174\/1568026615666150427124357","article-title":"Cardiovascular disease: a target for the pharmacological effects of quercetin","volume":"15","author":"Guillermo Gormaz","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26701_bib74","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10753-017-0680-8","article-title":"The falconoid luteolin mitigates the myocardial inflammatory response induced by high-carbohydrate\/high-fat diet in wistar rats","volume":"41","author":"Abu-Elsaad","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.heliyon.2024.e26701_bib75","series-title":"Luteolin Attenuates Atherosclerosis via Modulating Signal Transducer and Activator of Transcription 3-mediated Inflammatory Response","first-page":"3899","author":"Ding","year":"2019"},{"key":"10.1016\/j.heliyon.2024.e26701_bib76","first-page":"2593","article-title":"Luteolin decreases atherosclerosis in LDL receptor-deficient mice via a mechanism including decreasing AMPK-SIRT1 signaling in macrophages","volume":"16","author":"Li","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.heliyon.2024.e26701_bib77","doi-asserted-by":"crossref","first-page":"393","DOI":"10.12944\/CRNFSJ.7.2.09","article-title":"Luteolin in the management of type 2 diabetes mellitus","volume":"7","author":"Sangeetha","year":"2019","journal-title":"Current Research in Nutrition and Food Science Journal"},{"key":"10.1016\/j.heliyon.2024.e26701_bib78","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jep.2018.05.019","article-title":"Anti-inflammatory effects of luteolin: a review of in vitro, in vivo, and in silico studies","volume":"225","author":"Aziz","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e26701_bib79","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1055\/s-0028-1088314","article-title":"Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin","volume":"74","author":"Seelinger","year":"2008","journal-title":"Planta Med."},{"key":"10.1016\/j.heliyon.2024.e26701_bib80","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.1167\/iovs.11-8790","article-title":"Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production","volume":"53","author":"Park","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.heliyon.2024.e26701_bib81","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.toxlet.2021.03.006","article-title":"The genotoxicity potential of luteolin is enhanced by CYP1A1 and CYP1A2 in human lymphoblastoid TK6 cells","volume":"344","author":"Li","year":"2021","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.heliyon.2024.e26701_bib82","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cbi.2019.02.016","article-title":"Prenatal developmental toxicity evaluation of Verbena officinalis during gestation period in female Sprague-Dawley rats","volume":"304","author":"Fateh","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.heliyon.2024.e26701_bib83","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.etap.2015.03.013","article-title":"Polyphenols as possible bioprotectors against cytotoxicity and DNA damage induced by ochratoxin A","volume":"39","author":"Cariddi","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e26701_bib84","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1021\/acsomega.1c04239","article-title":"In silico, in vitro, and in vivo evaluation of the developmental toxicity, estrogenic activity, and Mutagenicity of four natural phenolic flavonoids at low exposure levels","volume":"7","author":"Zhang","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.heliyon.2024.e26701_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115380","article-title":"Co-administration of Luteolin mitigated toxicity in rats' lungs associated with doxorubicin treatment","volume":"411","author":"Owumi","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e26701_bib86","first-page":"1","article-title":"Evaluation of the effect of luteolin on the hepatic and hematopoietic systems in albino rats","volume":"10","author":"Orji","year":"2020","journal-title":"J. Clin. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e26701_bib87","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1158\/1940-6207.CAPR-13-0230","article-title":"Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity","volume":"7","author":"Majumdar","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.heliyon.2024.e26701_bib88","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.3390\/cancers14215373","article-title":"Luteolin, a potent anticancer compound: from chemistry to cellular interactions and synergetic perspectives","volume":"14","author":"Singh Tuli","year":"2022","journal-title":"Cancers"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024027324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024027324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:35:23Z","timestamp":1769045723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024027324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2405844024027324"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26701","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting luteolin: An updated review on its anticancer potential","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e26701"}}